Back to Rankings

BTMD

bioteD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
BTMD vs peer average
50/100
BTMD vs. peer average (D vs. D)
Grade spread
B 2 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ACTU is the first available peer comparator.

Included only as a sector and market-cap screen candidate. The available evidence does not establish a shared indication, product model, or commercial channel, so peer support remains weak and confidence is capped.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACTUActuate Therapeutics
BTMD
biote
ACTU
Actuate Therapeutics
Grade
D
N/A
Momentum
31
30
Value
72
-
Sentiment
40
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Unrated

Grade position vs ACTU

BTMD / ACTU
Grade Position
In line
BTMD vs. peer average (D vs. D)
50/100
Momentum
31
BTMD
Value
72
-
Sentiment
40
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BTMD
1
ACTU
ACTU
N/A
-
-
2
MNOV
MNOV
B
80/100
-2
3
SERA
SERA
F
20/100
+1
4
CSBR
Champions Oncology Inc Common
D
40/100
Even
5
EXOZ
eXoZymes Inc Common
N/A
-
-
ACTU is the first peer returned for this comparison set.